Vaccines News 14 August 2025

‘Superflu’ H3N2 K-Strain: Symptoms, Vaccine Protection and How the New Flu Variant Is Hitting Hospitals This Winter

Published: 9 December 2025 A heavily mutated flu strain — A/H3N2 subclade K, often dubbed the “K-strain” or “superflu” — is now dominating the 2025–26 flu season and driving record levels of illness in parts of the UK and beyond. On Tuesday, new analysis showed

9 December 2025

Moderna (MRNA) Stock Jumps on Vaccine Safety Study and $1.5B Lifeline: Latest News and Forecasts as of December 6, 2025

Moderna Inc. (NASDAQ: MRNA) is back in the spotlight. After months of pressure from collapsing COVID‑19 vaccine demand and rising regulatory scrutiny, the stock has staged a sharp rebound in early December 2025 — powered by a major long‑term safety

6 December 2025

Biotechnology · Financial Forecasts · Market News · NASDAQ:MRNA · Stocks · Vaccines

Moderna Stock Soars on Buyout Buzz – Can New Vaccines Fuel a Comeback?

Market Performance & Buyout Rumors On Oct. 30, 2025 Moderna’s stock jumped sharply. Midday trading saw MRNA up ~11.7% to about $27.56 tradingview.com, reversing much of September–October’s slide. This followed a STAT News report (cited by Reuters) that Moderna has

30 October 2025

Biotech News · Investing · NASDAQ:MRNA · Pharmaceuticals · Stock Market · Vaccines

CSL’s Vaccine Shock: Stock Plunges to 7-Year Low Amid Shareholder Revolt

Vaccine Slump Triggers Profit Downgrade and 7-Year Share Low CSL – Australia’s fourth-largest public company – stunned the market by cutting its profit outlook and delaying a major spinoff due to a steep and unexpected decline in flu vaccinations in the United

28 October 2025

Business News · Health Industry · NYSE:CSLLY · Shareholder Activism · Stock Market · Vaccines

Moderna’s Wild Ride: Vaccine Hopes Fuel Stock Pop Amid “One-Hit Wonder” Fears

Stock Rebounds on Moderna’s “Make-or-Break” Week Moderna’s stock is back in the spotlight after a turbulent week of news that sent the Nasdaq-listed shares swinging. On Wednesday, MRNA jumped over 5%, climbing to around $27.7 by market close marketbeat.com. The

16 October 2025

Biotechnology · COVID-19 · NASDAQ:MRNA · Pharma News · Stock Market · Vaccines

Game-Changing Vaccines, Breakthrough Drugs, and a CDC Shakeup: Biotech & Health News Roundup

In-Depth Report COVID-19 Vaccines and U.S. Public Health Upheaval Targeted Fall Boosters, But Access Tightened: U.S. health authorities approved new monovalent COVID-19 vaccines (by Pfizer–BioNTech, Moderna, and Novavax) updated for the 2025–26 season reuters.com. Unlike prior booster rollouts, the FDA

28 August 2025

Biotechnology · CDC · Health · Medicine · NASDAQ:JAZZ · NYSE:GSK · NYSE:LLY · NYSE:NVO · Vaccines

Miracle Cure, Mega-Deals & Vaccine Drama: Global Biotech & Health Roundup (Aug 13–14, 2025)

Breakthroughs in Biotech & Pharma Big Deals & Industry Moves Regulatory & Health Policy Updates Public Health Developments Noteworthy Medical Research Healthcare Technology & Innovation Sources: Official press releases, government health agency updates, and reputable media coverage were used in

14 August 2025

Biotech · Global News · Health · Medicine · NASDAQ:INSM · NASDAQ:RGEN · NYSE:NVS · Vaccines

Vaccines News 14 August 2025 - 9 December 2025